Clinical Trial Update: Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

View source ↗

Summary

A clinical trial evaluating whether plasma extracellular vesicle analysis can predict response to anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Non-Small Cell Lung Cancer, Melanoma (Skin Cancer) | Status: NOT_YET_RECRUITING